comparemela.com
Home
Live Updates
Us Multi Center - Breaking News
Pages:
Us Multi Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Paragonix Technologies SherpaPak Improves 1-Year Survival in Heart Transplant Patients in Real-World Study
GUARDIAN Registry data presented at ISHLT 2022 has shown a 72% reduction (p=0.005) in Severe PGD (primary graft dysfunction) and a 39% reduction (p=0.03) in Mechanical Circulatory Support, in addition to improvement in 1-year survival
United states
Marzia leacche
David dalessandro
Lisa anderson
Andreas zuckermann
Professor of surgery medical university vienna
Meeting of the international society for heart
Us multi center
Spectrum health
Paragonix technologies inc
Paragonix technologies
Paragonix sherpapak cardiac transport system
International society
Lung transplantation
Heart registry
Transplant survival analysis
vimarsana © 2020. All Rights Reserved.